Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stelara in active sight-threatening uveitis
NCT01647152Phase 2Withdrawn
- Sponsor
- National Eye Institute
- Start
- Jul 2012
- Primary completion
- Jun 2015
01
Overview
A Phase 2 trial of ustekinumab in Intermediate Uveitis (IU), Posterior Uveitis, panuveitis, sponsored by National Eye Institute. Planned start Jul 2012; status: withdrawn.
02
Drugs
ustekinumab
03
Conditions
Intermediate Uveitis (IU)Posterior Uveitispanuveitis
Beyond the preview
Go deeper on NCT01647152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01647152.